• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Forte Biosciences Inc (NQ: FBRX )

    0.5675 -0.0275 (-4.62%)
    Streaming Delayed Price Updated: 2:18 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 11,832
    Open 0.5600
    Bid (Size) 0.5650 (3)
    Ask (Size) 0.6100 (5)
    Prev. Close 0.5950
    Today's Range 0.5500 - 0.5800
    52wk Range 0.3800 - 1.030
    Shares Outstanding 21,051,195
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    FBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024
    Forte Biosciences just reported results for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -31.63%
    -31.63%
    1 Month
    +15.82%
    +15.82%
    3 Month
    -21.18%
    -21.18%
    6 Month
    -17.63%
    -17.63%
    1 Year
    -43.81%
    -43.81%

    More News

    Read More
    Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
    From Forte Biosciences, Inc.
    Via Business Wire
    FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023
    Via InvestorPlace
    Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
    From Forte Biosciences, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    Insiders Buying Vintage Wine Estates And 3 Other Stocks Under $1
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update
    From Forte Biosciences, Inc.
    Via Business Wire
    ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting
    From On behalf of Concerned Stockholders of Forte
    Via Business Wire
    Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom
    From On behalf of Concerned Stockholders of Forte
    Via Business Wire
    Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders
    From On behalf of Concerned Stockholders of Forte
    Via Business Wire
    Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
    From Forte Biosciences, Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
    From Forte Biosciences, Inc.
    Via Business Wire
    Earnings Scheduled For May 26, 2023
    Via Benzinga
    Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update
    From Forte Biosciences, Inc.
    Via Business Wire
    Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update
    From Forte Biosciences, Inc.
    Via Business Wire
    Mr. David Gryska Appointed to Forte Biosciences Board of Directors
    From Forte Biosciences, Inc.
    Via Business Wire
    Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
    From Forte Biosciences, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.